The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of Novavax’s https://www.reuters.com/markets/companies/NVAX.O” target=”_blank” rel=”noopener”>(NVAX.O) COVID-19 vaccine for emergency use in individuals aged 12 years and old…
Read More
About The Author
